Advisory Services Network, LLC Fate Therapeutics Inc Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$59.27 - $95.73 $5,927 - $9,573	-100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$67.25 - $92.52 $6,725 - $9,252	100 New	100 $9,000
Q1 2021 May 24, 2021	SELL	$72.16 - $117.4 $7,216 - $11,740	-100 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$38.09 - $100.95 $1,218 - $3,230	-32 Reduced 24.24%	100 $9,000
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $4,014 - $5,346	132 New	132 $5,000
Q2 2020 Aug 10, 2020	SELL	$20.21 - $35.23 $687 - $1,197	-34 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $69 - $127	-4 Reduced 10.53%	34 $1,000
Q4 2019 Feb 04, 2020	BUY	$13.39 - $20.73 $508 - $787	38 New	38 $1,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $235M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.